Orange Book product · Brand (NDA)
AGRYLIN
ANAGRELIDE HYDROCHLORIDE
At a glance
Mar 14, 1997
Approved
Brand (NDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 14, 1997
29 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
ANAGRELIDE HYDROCHLORIDE
Strength
EQ 0.5MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
NDA 020333
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2017ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 209151 · TORRENT
- 2006ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 077613 · RISING
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076530 · BARR LABS
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076683 · CHARTWELL RX
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076468 · CIPLA
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076910 · IMPAX LABS
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076811 · NOVITIUM PHARMA
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076489 · ROXANE
- 2005ANAGRELIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 076417 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
